Patent · US Active

Antibodies against human CSF-1R and uses thereof

US10287358B2 · kind B2 · utility

3Cited by
39References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 2018
Grant dateMay 14, 2019
Priority date
Expiry dateAug 6, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.